These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 34470570)
1. Obstetric anti-phospholipid syndrome: from pathogenesis to treatment. Kaneko K; Ozawa N; Murashima A Immunol Med; 2022 Jun; 45(2):79-93. PubMed ID: 34470570 [TBL] [Abstract][Full Text] [Related]
2. [Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues]. Gao R; Qin L Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):513-520. PubMed ID: 38948301 [TBL] [Abstract][Full Text] [Related]
3. Obstetric Anti-phospholipid Syndrome: State of the Art. Gerardi MC; Fernandes MA; Tincani A; Andreoli L Curr Rheumatol Rep; 2018 Aug; 20(10):59. PubMed ID: 30105597 [TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases. Khizroeva J; Bitsadze V; Tincani A; Makatsariya A; Arslanbekova M; Babaeva N; Tsibizova V; Shkoda A; Makatsariya N; Tretyakova M; Solopova A; Gadaeva Z; Vorobev A; Khamani I; Aslanova Z; Nakaidze I; Mischenko A; Grigoreva K; Kunesko N; Egorova E; Mashkova T J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6157-6164. PubMed ID: 34044735 [TBL] [Abstract][Full Text] [Related]
5. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL]. Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771 [TBL] [Abstract][Full Text] [Related]
7. Obstetric antiphospholipid syndrome: an update on pathophysiology and management. Ernest JM; Marshburn PB; Kutteh WH Semin Reprod Med; 2011 Nov; 29(6):522-39. PubMed ID: 22161465 [TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature. Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906 [TBL] [Abstract][Full Text] [Related]
9. Current insights in obstetric antiphospholipid syndrome. Schreiber K; Radin M; Sciascia S Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160 [TBL] [Abstract][Full Text] [Related]
10. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. de Jesus GR; Agmon-Levin N; Andrade CA; Andreoli L; Chighizola CB; Porter TF; Salmon J; Silver RM; Tincani A; Branch DW Autoimmun Rev; 2014 Aug; 13(8):795-813. PubMed ID: 24650941 [TBL] [Abstract][Full Text] [Related]
18. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Gerde M; Ibarra E; Mac Kenzie R; Fernandez Suarez C; Heer C; Alvarez R; Iglesias M; Balparda J; Beruti E; Rubinstein F Thromb Res; 2021 Oct; 206():104-110. PubMed ID: 34454240 [TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome]. Li XY; Zhao JX; Liu XY Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):956-961. PubMed ID: 30562764 [TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome. De Carolis S; Tabacco S; Rizzo F; Giannini A; Botta A; Salvi S; Garufi C; Benedetti Panici P; Lanzone A Autoimmun Rev; 2018 Oct; 17(10):956-966. PubMed ID: 30118899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]